Abstract Two decades after signals controlling bone length were discovered, the endogenous ligands determining bone width remain unknown. We show that postnatal establishment of normal bone width in mice, as mediated by bone-forming activity of the periosteum, requires BMP signaling at the innermost layer of the periosteal niche. This developmental signaling center becomes quiescent during adult life. Its reactivation however, is necessary for periosteal growth, enhanced bone strength, and accelerated fracture repair in response to bone-anabolic therapies used in clinical orthopedic settings. Although many BMPs are expressed in bone, periosteal BMP signaling and bone formation require only Bmp2 in the Prx1-Cre lineage. Mechanistically, BMP2 functions downstream of Lrp5/6 pathway to activate a conserved regulatory element upstream of Sp7 via recruitment of Smad1 and Grhl3. Consistent with our findings, human variants of BMP2 and GRHL3 are associated with increased risk of fractures.
Introduction
After birth, the skeleton sustains a period of exuberant longitudinal and periosteal growth, the respective processes by which bones grow in length and width (Salazar et al., 2016a) . Since increased length and increased width have opposite effects on susceptibility to fracture, longitudinal and periosteal growth must be tightly coupled to build a skeleton that supports body weight and motion during postnatal life (Pathria et al., 2016; Davison et al., 2006) . Longitudinal growth is mediated by growth plate cartilage. Defects in longitudinal growth are well documented in the dwarfism resulting from genetic mutations of FGFR3 (MIM100800) (Ornitz and Legeai-Mallet, 2017) , PTHR1 (MIM156400) (Schipani and Provot, 2003) , or GDF5 (MIM200700) (Salazar et al., 2016a) . Periosteal growth is mediated by the periosteum. Although excessive periosteal bone formation is linked to activating mutations of the canonical WNT pathway (Baron and Kneissel, 2013) , accounts of defective periosteal growth in humans are extremely rare (Bonafe et al., 2015) . The identity of the essential signal governing periosteal activity during early postnatal life therefore remains unknown. It also remains unclear whether functions of the adult periosteum, including fracture repair and cortical expansion in response to therapeutic agents, rely on reactivation of this putative developmental signal.
The periosteum is a stratified fibro-cellular structure that adds tissue to the exterior surfaces of bone, much like rings on the trunk of an actively growing tree (Dwek, 2010) . The outer periosteum provides a collagen-rich barrier between muscle and the underlying bone and is the site of insertion for tendons and ligaments. It is highly vascularized, innervated, and sparsely populated by fibroblasts. The cambium, or inner periosteal layer adjacent to bone, is a repository for self-renewing skeletal progenitors that differentiate into bone-forming osteoblasts (Dwek, 2010) . The periosteum is thick and highly active during pre-pubertal growth but becomes thin and largely quiescent in adult life. The molecular mechanism controlling the conversion between active and quiescent periosteal states is not well understood.
Since Bmp2 is essential for initiation of fracture repair (Tsuji et al., 2006) , we hypothesized that Bmp2 governs all major developmental and inducible functions of the periosteal niche. To test this, we performed skeletal phenotype analysis of mice where Bmp2 was selectively ablated in progenitor, committed, or mature osteoblast populations. We mapped the endogenous Bmp2 expression domain and compared this to the BMP signaling domain during skeletal development and homeostasis. Periosteal growth and fracture phenotypes of Bmp2 mutant mice were monitored following genetic or pharmacologic activation of the LRP5/6 signaling pathway. We investigated recruitment of pathway-specific transcription factors to genome-wide cis-regulatory elements, establishing at the molecular level the epistatic relationship between canonical WNT and BMP2 signaling during osteoblast differentiation. And finally, we performed phenome wide analysis to test links between our preclinical data and fracture risk in clinical settings.
Results
Osteoprogenitor-derived BMP2 couples longitudinal to periosteal bone growth
Removal of Bmp2 from the developing mouse limb (Bmp2
Flox/Flox ; Prx1-Cre) causes spontaneous fractures that do not heal (Tsuji et al., 2006) . Fracture repair and bone graft healing were rescued in Bmp2-deficient bones by provision of recombinant BMP2 (Chappuis et al., 2012) , however the underlying cause of the spontaneous fractures remained unknown. During skeletal phenotyping, microcomputed tomography (microCT) revealed that Bmp2 Flox/Flox (WT) femurs ( Figure 1a ) and
Bmp2
Flox/Flox ; Prx1-Cre (Bmp2 Prx1-cKO) femurs ( Figure 1b) were indistinguishable at birth. Bmp2
Prx1-cKO femurs developed a striking geometry after birth, characterized by near normal length ( Figure 1c ) but narrow width ( Figure 1d ). In the radius/ulna, defective periosteal bone growth was not evident at birth (Figure 1e-f), but appeared by 2 weeks of age (Figure 1g -h) and remained unresolved during adult life. The radius/ulna of WT and Bmp2 Prx1-cKO mice contained similar proportions of cortical bone and medullary space at birth ( Figure 1i) . By 2 weeks, forelimb structures of Bmp2 Prx1-cKO mice were composed primarily of cortical bone ( Figure 1j ) despite the total crosssectional area being dramatically reduced compared to controls. This slender bone phenotype was not restricted to the radius/ulna ( Figure 1g ) and femur ( Figure 1k ) but appeared at all appendicular skeletal sites including the tibia ( Figure 1l ) and metatarsals ( Figure 1m ). Osteopenia was not evident in the axial skeleton where Prx1-Cre is not active (Durland et al., 2008; Logan et al., 2002) . Defective periosteal bone growth occurred in males and females and was therefore unlikely to be caused by sex hormones. IGF-1 signaling can affect bone width (Lindsey and Mohan, 2016) , but Bmp2 Prx1-cKO mice expressed IGF-1 in bone (Figure 1-figure supplement 1a ) and circulating IGF-1 was statistically unchanged in Bmp2 Prx1-cKO mice (Figure 1-figure supplement 1b) . During ex vivo organ culture, WT and Bmp2 Prx1-cKO metatarsals were equal in length on day one and both grew in culture (Figure 1n ). WT and Bmp2 Prx1-cKO metatarsals were equal in width on day 1, but only WT metatarsals grew in width during culture ( Figure 1o ). Bmp2 is essential for conversion of Runx2+ osteoprogenitors to the Sp7+ osteoblast cell fate in primary cell models (Salazar et al., 2016b) . Consistent with these in vitro observations, mice with conditional ablation of Bmp2 in skeletal progenitors (Bmp2 Prx1-cKO) (Figure 1p ), but not committed osteoblasts (Bmp2 Table 1) . Geometric abnormalities plus material defects underlie spontaneous fractures in Bmp2 Flox/Flox ; Prx1-Cre mice
Beyond the slender bone phenotype, Bmp2 Prx1-cKO mice exhibited no differences in skeletal patterning when imaged by X-ray at 3 months of age ( Figure 1-figure supplement 3a) . Closer examination of Bmp2 Prx1-cKO bones at 2 weeks of age by microCT revealed trabecular bone content and tissue mineral density were unaffected by the absence of Bmp2 (Figure 1 -figure supplement 3b and Table 2 ), despite significant reductions in bone width ( Figure 1-figure supplement 3c) , total cross-sectional area (Tt.Ar), marrow area (Ma.Ar), and minimum moment of inertia (I MIN ) ( Table 2) . Static histomorphometry disclosed decreased numbers of osteoblasts but not osteoclasts per unit of bone surface (Figure 1-figure supplement 3d) . Bone formation and mineral apposition rates were similar at endosteal sites but dramatically reduced at periosteal sites in Bmp2 Prx1-cKO mice (Figure 1 -figure supplement 3e-h). We found abundant cortical porosity (Figure 1 -figure supplement 3i) with residual islands of cartilage and excessive numbers of osteocytes in Bmp2 Prx1-cKO bones (Figure 1-figure supplement 3j ). Under polarizing light microcopy, collagen in Bmp2 Prx1-cKO cortical bone had a woven appearance compared to lamellar organization in WT bone ( Figure 1-figure supplement 3k,l) . Bmp2 Prx1-cKO bones had increased osteoid thickness and a prolonged mineralization lag time on periosteal but not endosteal surfaces (Figure 1 -figure supplement 3m-p).
Overall, dramatically reduced polar moment of inertia ( Figure 1 -figure supplement 1s) and impaired material properties of Bmp2 Prx1-cKO bones likely caused microcracks ( Figure 1t ) and bowing ( Figure 1u ), factors preceding onset of frank fractures (Tsuji et al., 2006). Bmp2 is expressed at the right time and place to regulate periosteum formation and/or function (Monteiro et al., 2008) . At E13.5, GFP+ cells flanked cartilage rudiments of the forelimb (Figure 3a) . In newborn forelimbs, GFP+ cells co-localized with mineralized bone (Figure 3b) , the entire length of the newly-formed bone collar (Figure 3c , white arrows and red dashed line), as well as hypertrophic cells in growth plate cartilage (Figure 3c , open red arrows). In hindlimbs at 2 weeks, GFP+ cells surrounded trabecular structures in the medullary cavity and populated the inner layer of the periosteum (Figure 3d, mice attained peak skeletal size, GFP expression had become quiescent at bone surfaces and was restricted to pockets of cells in the marrow (Figure 3f) .
Cells with active BMP pathway are therefore abundant in newly-forming bone at mid-gestation and neonatal stages. A distinct GFP+ population demarcating the bone collar at birth transitions to a robust GFP+ inner periosteal layer flanking the diaphysis by 2 weeks of age, and subsequently remains as a sparsely GFP+ periosteal population in adult bones at homeostasis. Importantly, BRE:gfp is not specific for BMP2 signaling, but rather integrates the net response of a cell to all local BMPs and BMP antagonists. Consistent with the cortical but not trabecular skeletal phenotype of Bmp2 Prx1-cKO mice , this comparative analysis of Bmp2-lacz versus BRE:gfp strongly suggests BMP2 is the major BMP family member driving BMP signaling at periosteal but not necessarily trabecular sites.
Bmp2 is required for BMP signaling and expression of BMP target genes in the periosteum
We next determined if the periosteum forms in Bmp2 Prx1-cKO mice and if it engages in BMP signaling. Picrosirius red histology revealed that embryonic development and postnatal maintenance of the periosteum occur independently of Bmp2 expression in the Prx1-Cre lineage (Figure 4a-c) . By contrast, BMP2 is necessary for phospho-activation of Smads1/5 at inner periosteal but not endosteal bone surfaces. This was evident at birth ( Figure 5a ) and became pronounced by 2 weeks of age ( Figure 5b ). Immunohistochemistry for ID1 protein, a BMP-target gene, showed that ID1+ cells were abundant in the periosteum of WT but not Bmp2 Prx1-cKO mice ( Figure 5c ). We performed in situ hybridization for Col1a1, encoding the major extracellular matrix protein produced by osteoblasts. Wild-type but not Bmp2 Prx1-cKO mice expressed Col1a1 in the periosteum ( Figure 5d ). Periosteal BMP2 signaling is therefore necessary for osteoblast specification in the periosteal niche.
Bmp2 acts downstream of intermittent PTH therapy in the periosteum
Intermittent parathyroid hormone (PTH) therapy and sclerostin neutralizing antibody (SOST-ab) are two successful clinical approaches to stimulate the periosteum for periosteal growth and accelerated fracture repair (Baron and Kneissel, 2013; Collinge and Favela, 2016; Einhorn and Gerstenfeld, 2015) . PTH is a naturally occurring hormone that regulates mineral homeostasis via endocrine actions on multiple organs including bone. Intermittent exposure to PTH (iPTH) through once daily injections of hPTH 1-34 peptide results in a net surplus of new bone formation (Neer et al., 2001 ). The mechanism of action for iPTH therapy continues to generate considerable discussion and PTH has been reported to induce expression of Bmp2 in osteoblast cultures (Zhang et al., 2011) . To examine the interaction between PTH and Bmp2 in the periosteum, we treated 2 week-old Bmp2 Prx1-cKO mice with iPTH for 14 days and monitored periosteal bone growth in the now 1 month-old treated juveniles (Figure 6a ). At 2 weeks of age, WT and Bmp2 Prx1-cKO mice responded to iPTH with increased trabecular bone mass ( Figure 6b ,d,f and Table 3 ). WT but not Bmp2 Prx1-cKO mice exhibited a trend for periosteal expansion ( Figure 6c ,e,g and Table 3 ), although this was not statistically significant and it is plausible that additional treatment time was necessary to achieve sufficient cumulative periosteal growth to become measurable by microCT. WT and Bmp2 Prx1-cKO mice had elevated serum calcium and reduced serum phosphorus levels following iPTH (Figure 6l ,m). Bone formation rate and mineral apposition rate were significantly blunted at periosteal but not endosteal surfaces of cortical bone in Bmp2 Prx1-cKO mice, and were not elevated to the levels achieved in WT mice following treatment with iPTH ( Figure 6h-k) . WT but not Bmp2 Prx1-cKO mice treated with iPTH expressed ID3, a BMP target gene, in the periosteum (Figure 6n ), whereas both genotypes had ID3+ cells in endosteal compartments ( Figure 6n , blue lines).
In adults treated for two weeks with iPTH ( Figure 7a ), WT and Bmp2 Prx1-cKO mice had increased trabecular bone mass following iPTH ( Figure 7b and Table 4 ). To evaluate biomechanical properties in the femur, peak moment (maximum load during failure in three-point bending (Makowski et al., 2014) ) was plotted as a function of I MIN /C MIN . WT mice experienced much greater cortical expansion with iPTH than Bmp2 Prx1-cKO mice, as evident by cross-sectional ratio proportional to bending moment (Figure 7c ), and moment of inertia that is predominantly influenced by the periosteal perimeter (Table 4) . Functionally, iPTH-treated Bmp2 Prx1-cKO mice were 2-4 times more likely than non-iPTH treated knockouts to experience femoral fracture ( Figure 7e fractures in Bmp2 Prx1-cKO mice treated with iPTH shifted from unilateral to bilateral occurrence (Figure 7f,g ). Fracture incidence was not improved by increasing iPTH therapy to 3 weeks. Existing fractures remained unhealed (Figure 7h) . Expression of Bmp2 in the Prx1-Cre lineage is therefore a major if not essential contributor to the mechanism of action by which iPTH stimulates the periosteum for periosteal bone growth and conclusively essential for the mechanism by which PTH improves bending strength and stimulates the periosteum for fracture repair.
Bmp2 acts downstream of canonical WNT signaling in the periosteum
Haploinsufficiency of Dkk1, a secreted antagonist of LRP5/6, enhances canonical WNT signaling and induces high bone mass in mice (Morvan et al., 2006) , findings that prompted efforts to develop DKK1 neutralizing antibodies for systemic activation of bone formation in clinical orthopedic settings (Ke et al., 2012) . Haploinsufficiency of Dkk1 (Dkk1 +/-) was recently reported to have no effect on the formation or healing of spontaneous fractures in adult mice lacking Bmp2 (Dkk1
Prx1-Cre) (Intini and Nyman, 2015) . However, DKK1 neutralizing antibodies have been shown to enhance bone formation in younger animals to a greater degree than in older animals (Ke et al., 2012) . We therefore revisited this genetic mouse model to determine whether activation of WNT signaling through haploinsufficiency of Dkk1 could restore periosteal bone growth in young Bmp2 Prx1-cKO mice, when the skeletal phenotype is first established and thus prior to the onset of fractures ( Figure 8a ). By 2 weeks of age, trabecular bone mass was elevated by haploinsufficiency of Dkk1, and this was not dependent on Bmp2 (data not shown). Bmp2 Prx1-cKO mice developed ã 75% decrease in calculated cross-sectional moment of inertia at the femoral mid-diaphysis that was neither rescued nor altered by haploinsufficiency of Dkk1 (Figure 8b-c) .
Since haploinsufficiency of Dkk1 did not affect periosteal growth in young (Figure 8a -c) or aged mice (Intini and Nyman, 2015) , regardless of Bmp2 status, we chose sclerostin neutralizing antibody (SOST-ab) as an alternative method to stimulate canonical WNT signaling in bone and thereby activate the periosteum. Adult mice were treated for 2 weeks with SOST-ab ( Figure 8d) . WT males treated with SOST-ab had a significant increase in trabecular bone (almost 88%). Bmp2 Prx1-cKO male mice undergoing SOST-ab treatment had˜32% more trabecular bone than saline treated knockouts, an anabolic trend that reached statistical significance in females but not males (Figure 8e -f, and Source Data). At the mid-diaphysis (Figure 8g-j) , WT mice treated with SOST-ab significantly enhanced total cross-sectional area (p=0.01; Figure 8h ), minimum moment of inertia (p<0.0001; Figure 8i) , and polar moment of inertia (p=0.0004; Figure 8j ) when compared to nontreated genotype-matched and sex-matched controls. These parameters of cortical bone mass and strength were unchanged in Bmp2 Prx1-cKO mice treated with SOST-ab (Figure 8g-j and Source Data). The number of forelimb fractures in Bmp2 Prx1-cKO mice was not reduced by SOST-ab ( Figure 8k ) and these fractures showed no radiographic evidence of mineralized bridging (Figure 8l) .
The abundance of phospho-activated Smads1/5 in bone lysates ( Figure 9a ) and alkaline phosphatase activity in the periosteum (Figure 9b) were increased 24 hr after one injection of PTH or SOSTab. Crossing the BRE:gfp reporter into a Bmp2 Prx1-cKO background revealed that SOST-ab dramatically upregulates periosteal BMP signaling in WT but not Bmp2 Prx1-cKO mice, an effect evident after 72 hr (Figure 9c and Figure 9 -figure supplement 1) or two weeks of treatment Expression of Bmp2 in the Prx1-Cre lineage is therefore essential to the mechanism of action by which SOST-ab stimulates the periosteum for periosteal bone growth and fracture repair.
Bmp2 functions downstream of canonical WNT signaling in the osteoblast gene regulatory network Periosteal cells isolated from long bones of 2 week-old mice express Bmp2 and Bmp7 mRNAs, but nearly undetectable levels of Bmp4. Cre-mediated deletion of Bmp2 is highly efficient in Bmp2 Prx1-cKO cells and does not induce Bmp7 or Bmp4 to compensate (Figure 10a,b) . Primary periosteal cells from Bmp2 Prx1-cKO mice were unable to be expanded or maintained without complementation by recombinant BMP2. Cells from the bone marrow stroma (BMSC) or embryonic mouse limb bud were therefore employed for mechanistic studies since we have previously demonstrated that unresponsiveness of Bmp2-deficient osteoprogenitors to canonical WNT signaling can be recapitulated using these in vitro models (Salazar et al., 2016b) . In BMSC, an optimal ratio of BMP to WNT signaling must be maintained for osteoblast differentiation (Figure 10c,d) . Bmp2 Prx1-cKO cells exposed to Wnt3a do not upregulate Sp7 (a transcription factor required for osteoblast specification (Rodda and McMahon, 2006; Nakashima et al., 2002) unless supplemented with recombinant BMP2 (Salazar et al., 2016b) . Consistent with the observation that Bmp7 is expressed (Figure 10b ) but does not compensate for lack of Bmp2 in periosteal cells in vivo, equivalent concentrations of recombinant BMP7 and GDF5 did not functionally compensate in vitro for lack of BMP2 in BMSC (Figure 10e) .
Bmp2 Prx1-cKO cells exposed to Wnt3a also do not upregulate Grainyhead-like 3 (Grhl3), a transcription factor co-expressed with Bmp2 and Lrp5/6 during embryonic skeletal development and fracture repair in adult bones (Salazar et al., 2016b) . In vitro analysis suggested Grhl3 is necessary and sufficient for induction of Sp7 by BMP2 (Salazar et al., 2016b) . We thus investigated the relationship between WNT, BMP2, Sp7, and Grhl3 in the osteoblast gene regulatory network and used Flox/Flox ; Prx1-Cre mice after intermittent PTH therapy.
Ten week-old mice were given intermittent PTH 1-34 therapy (100 mg/kg, subcutaneous) for 14 days. Bone mass was analyzed in the femur by microcomputed tomography (microCT cells from the mouse embryonic limb bud for the following reasons: early post-natal cortical bone where our phenotype of interest occurs, derives from the embryonic bone collar that forms at the perichondrium at˜E15.5; this bone collar is made by Sp7+ cells that first emerge at the perichondrium at E13.5 (Rodda and McMahon, 2006) , subsequently populate the post-natal periosteum and persist for the first month of life (Maes et al., 2010) ; Sp7+ cells that appear at E13.5 are specified from lateral plate mesoderm of the Prx1+ limb bud (Nishimura et al., 2012; Martin et al., 1995) ; Prx1+ limb bud first appears at˜E9.5 (Logan et al., 2002) . The gene regulatory network that specifies Sp7+ cells that make the bone collar and populate the early postnatal periosteum must therefore be highly active in the limb bud between E9.5-E13.5. In a WNT-ON state, activated canonical WNT transcription factor complexes, comprised of b-catenin and co-factors such as Pygo and Bcl9 (Städeli and Basler, 2005) , assemble at genomic WNTresponsive elements via interaction with DNA-binding members of the TCF/LEF family. In a WNT-OFF state, TCF/LEF proteins are constitutively bound to chromatin where they function as transcriptional repressors of their bound target genes. Since TCF pulldown is therefore not able to discriminate between genes that are being repressed or induced, we performed anti-Bcl9 ChIP-sequencing (Cantù et al., 2017) limb buds (Figure 11a ). We discovered 2099 high-confidence Bcl9 peaks enriched at gene loci involved in limb, skeletal, and bone morphogenesis ( Figure 11b ) along with previously established canonical WNT target genes to confirm that the strategy had worked (Figure 11c,d) . KEGG pathway analysis also revealed prominent association of Bcl9 peaks with WNT, TGF-beta, Shh, and Hippo pathways ( Figure 11b) . Importantly, Bcl9 peaks marked multiple regions, including transcriptional start sites, surrounding Bmp2 and Grhl3 loci, suggesting direct transcriptional regulation (Figure 11e,f) . A Bcl9 peak downstream of Sp7 did not pass statistical threshold. WNT-dependent transcription is therefore already active but does not directly target Sp7 in the E10.5 limb bud, compatible with the observation that Sp7+ osteoblasts do not appear until˜E13.5 (Rodda and McMahon, 2006) . Consistent with the conclusion that Bmp2 is a WNT target gene, recombinant Wnt3a induced Bmp2 in limb bud cells (Figure 11-figure supplement 1a) . By contrast, chromatin IP qPCR analysis on E13.5 mouse limb bud cells (Figure 12a ) revealed BMP-dependent recruitment of Smad1 and Grhl3 to a genomic site 13 kb upstream of Sp7 (Figure 12b,c) . This site was enriched for active chromatin histone marks and evolutionarily conserved (Figure 12c) , supporting a cis-regulatory function. In turn, Sp7 is essential for bone formation through direct cis-regulatory control of Col1A1 (Hojo et al., 2016) . This major extracellular matrix protein produced by osteoblasts expressed in wild-type but not Bmp2 Prx1-cKO periosteum (Figure 5d Human variants of BMP2 and GRHL3 are associated with increased risk of fracture BMP2 variants predicted to result in haploinsufficiency are associated with short stature, craniofacial gestalt, skeletal anomalies, and congenital heart disease (Tan et al., 2017) . To further evaluate the clinical consequences of BMP2 variation, we performed a phenomewide association study of BMP2 and a downstream effector GRHL3 in 61,062 individuals from DiscovEHR (http://www.discovehrshare.com/), a cohort linking exome sequence data to electronic health records (EHRs) (Dewey et al., 2016) . Using a Bonferroni significance threshold of p<1.86e-7 for 268,192 association results, we observed three significant associations for BMP2 and six significant associations for GRHL3. Of note, there was a significant association between a missense variant in BMP2 (p. Arg131Ser) and increased risk of lower leg fracture (odds ratio (OR) 16.05, 95% confidence interval (CI) 6.44-40.00, p=2.54e-9), consistent with previous data on BMP2 haploinsufficiency and observations in the conditional knockout mouse. Moreover, significant associations were observed between a synonymous variant in GRHL3 and increased risk of fracture of thoracic vertebra (OR = 12.72, and between an intronic variant in GRHL3 and increased risk of fracture of patella (OR = 13.33, 95% CI 5.11-34.81, p=1.22e-7) ( Table 5) .
In summary, our data demonstrate that skeletal development, fracture repair, and therapeutic response to systemic treatment with PTH or SOST-ab all converge on expression of Bmp2 in the periosteal niche for control of osteoblast specification and periosteal function (Figure 13a) .
Discussion
Whereas the signaling mechanisms controlling longitudinal growth by the growth plate were initially described in 1996 Vortkamp et al., 1996) , the mechanisms underlying periosteal growth by the periosteum, the primary determinant of bone width and therefore bone strength, have remained unknown. Here we reveal that Bmp2 governs all thus-far identified developmental, clinically-inducible and repair functions of the periosteum. Bmp2 is dispensable for periosteum formation, but essential for osteoblast differentiation from periosteal progenitors, and thereby periosteal bone growth and fracture repair. Local BMP2 expression regulates BMP signaling in the periosteal niche during this process and drives periosteal response to canonical WNT and PTH signals. Global loss of Bmp2 is embryonic lethal, explaining why the identity of a signal controlling periosteal bone growth, a postnatal function, eluded us for so long. The slender bone phenotype in Bmp2 Prx1-cKO mice, established by 2 weeks of age, is not recapitulated by omission of any other BMP from bone (Salazar et al., 2016a) , nor is it present when Bmp2 is deleted in more specified skeletal progenitors expressing Sp7-EGFP::Cre or 2.3kb-Col1a1-Cre.
Our work reveals the innermost layer of periosteum as a robust BMP signaling center and identifies pre-Sp7 +progenitors as a critical source and target for BMP2. Cells in the outer periosteum and within cortical bone are not highly engaged in BMP signaling. BMP2 availability in bone therefore appears to be tightly regulated, perhaps through sequestration of BMP2 in the extra-cellular matrix. Comparative analysis of Bmp2 lacz with BRE:gfp strongly suggests that cortical bone matrix functions as a BMP2 repository, allowing only local activation of cells at the innermost cambial periosteal layer. Future studies uncovering the mechanisms that restrict BMP2 bioavailability to the periosteum could uncover new strategies to improve bone width, resistance to fracture, and bone repair. Excessive LRP5/6 signaling underlies several human skeletal disorders characterized in part by exuberant periosteal expansion (Baron and Kneissel, 2013) . Strikingly however, periosteal growth and fracture repair defects in Bmp2 cKO mice were not rescued by haploinsufficiency of Dkk1, iPTH therapy, or treatment with SOST-ab. We propose that LRP5/6-dependent pathways initiating periosteal bone formation in the postnatal skeleton converge on upregulation of Bmp2 for induction of BMP signaling. BMP2 signaling, by coordinating assembly of a Smad/Grhl3 complex at the Sp7 genomic locus, thereby acts downstream of canonical WNT to specify the Sp7+/Col1A1+ cells required for periosteal growth and fracture repair.
Looking forward, we find a lack of information and understanding of the signals mediating normal BMP2 expression in the periosteal niche, both as a function of age and in the context of skeletal disease. This information is key to modulating skeletal stem cell behavior to improve healing and in response to therapeutic agents. As all of our experiments are done in the total absence of periosteal BMP2, the information needed to figure out this part of the puzzle remains elusive, especially since deposition of BMP2 in bone and new synthesis of BMP2 are both missing in our mice. An abundance of cis-regulatory elements in the BMP2 gene desert mediate precise spatiotemporal control of BMP2 during development and repair, and this could potentially be exploited for screens identifying improved and more controlled methods of bone repair mediated by endogenous expression of Bmp2.
In summary, the dynamic spatiotemporal expression pattern of Bmp2 constitutes an essential mechanism determining active versus quiescent states of the periosteal niche throughout embryonic and postnatal life. We identify Bmp2 as the signal that couples bone length to bone width during development and demonstrate that reactivation of this developmental signaling center is the essential mechanism by which bone anabolic therapies recruit the periosteum to reduce fracture risk and accelerate fracture repair. 
Materials and methods

Key resources table
Animals
In vivo experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals and were approved by the Harvard Medical Area Institutional Animal Care and Use Committee (protocol #04043 to V.R.). Mice bearing alleles where loxP sites flank the coding sequence of exon 3 of Bmp2 (Bmp2 F/F ) were bred to Prx1-Cre mice (B6.Cg-Tg(Prrx1-cre)1Cjt/J) (Logan et al., 2002) , Sp7-GFP::Cre mice (B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J) (Rodda and McMahon, 2006) , or 2.3kb-Col1A1-Cre mice (Tg(Col1a1-cre)1Kry) (Dacquin et al., 2002) (Monteiro et al., 2008) were a kind gift of Dr. Christine Mummery.
Bone measurements
Femoral length and width (antero/posterior) were measured in fresh collected bones using a digital caliper (Ted Pella, Inc) (8-20 per age and per genotype). Percentage of tissue area and cross-sectional composition ( Figure 1) were calculated based on areal measurements obtained with ImageJ Software areal measurement tool. The whole radius from newborn (n = 6-9) and P14 (n = 3-9) Bmp2 Prx1-cKO mice and control littermates were sectioned from distal to proximal. One section every 50 
Radiographs
Imaging was done post-mortem in a Bruker MS-Fx-Pro using 45 kVp of radiation energy and a 30 s exposure time.
Micro-CT and bone strength assessment
Femora were scanned post-mortem with a mCT40 (Scanco Medical AG, Switzerland). The mid-shaft of the diaphysis was analyzed using a 12 mm voxel size, 70 kVp/145 mA of radiation energy and a 300 msec integration time. Contouring was performed using a threshold of 220 for trabecular bone (450.7 mgHA/cm 3 ) or 334 for cortical bone (787.7 mgHA/cm 3 ). We quantified the average moment of inertia (I MIN ), and the average total cross-sectional area of bone tissue (Ct.Ar). To assess structural strength, hydrated femurs were loaded in three-point bending to determine the peak moment (maximum force x span) endured by each bone (Makowski et al., 2014) . For the estimated material properties reported in supplemental materials, we used standard flexural formula (maximum force x span x C MIN /I MIN ) from beam theory the structural properties from microCT. Data are reported as mean ±s.d, where p-value was calculated using 1-way ANOVA and post-test Newman Keulus. All data points were included in the analysis. Figure 13 . Intermittent parathyroid hormone Two week-old Bmp2 Prx1-cKO mice and control littermates were assigned to treatment groups (n = 5-8 per group). PTH 1-34 (hPTH (1-34) ; Bachem, Bubendorf, Switzerland) was administered at 100 mg/kg/day (Kramer et al., 2010) for 2 weeks by subcutaneous injections or equivalent volume of vehicle (phosphate-buffered saline, pH 7.4) seven days per week. Seven week-old male Bmp2 Prx1-cKO mice and control littermates were treated for 3 weeks with PTH 1-34 or vehicle five days per week (n = 4-8). Mice were sacrificed 2 hr after the final PTH injection, followed by exsanguination and tissue collection for further analysis.
A
Histomorphometry
Static and dynamic histomorphometry measurements were analyzed between 4 week-old or 10 week-old Bmp2 Prx1-cKO mice and control littermates treated or not treated with hPTH. In the first set of experiments (2 to 4 weeks of age) mice were injected with demeclocycline hydrochloride (40 mg/kg) for 4 days before euthanasia and with calcein (20 mg/kg) 1 day before euthanasia (Fonseca et al., 2011) . In the second set of experiments (7 to 10 weeks of age) the same doses of demeclocycline and calcein were administered, but 8 and 2 days before euthanasia (Guo et al., 2010) . Kinetic bone parameters were obtained from unstained 10 mm sections examined by fluorescent light microscopy. The static and dynamic histomorphometric indexes were evaluated in trabecular and cortical bone in sagittal and transversal sections. Periosteal and endosteal parameters were evaluated as described previously (Millard et al., 2011) .
Sclerostin-neutralizing antibody
SOST-ab (provided by A. Economides at Regeneron) was prepared in sterile saline and delivered via subcutaneous injection at a dose of 20 mg/kg, twice per week for 2 weeks. Diluted antibody was stored in single-use aliquots at À80˚C.
Histology
Samples removed for histology were fixed in 4% paraformaldehyde, decalcified in Tris buffer containing 10% EDTA and embedded in paraffin. Sections (5 mm thick) were stained with 0.1% toluidine blue using standard procedures. Immunolocalization was performed as described (Retting et al., 2009; Lowery et al., 2010) . Briefly, sections were digested with trypsin (1% in PBS) for 10 min at 37˚C and then boiled for 15 min in citrate buffer (Ivkovic et al., 2003) . Sections were blocked with 5% goat serum for 1 hr and incubated with primary antibody overnight at 4˚C, followed by incubation with secondary antibody for 1 hr at room temperature, then with fluorophore for 30 min at room temperature or incubated with Vector Elite ABC reagent (Vector) for 60 min before developing with diaminobenzidine. Primary antibodies were as follows: anti-pSMADS (Cell Signaling); anti-ID1 and ID3 (BioCheck); anti-IGF1 (Abcam). Secondary antibodies were conjugated with AlexaFluor-555 and AlexaFluor-488 for immunofluorescence and sections were counterstained with DAPI (Vectashield). Secondary antibodies were conjugated with biotin for immunohistochemistry and sections were counterstained with toluidine blue or methyl green. Digital images were obtained using a Zeiss AxioImager MI Microscope fitted with an AxioCam HRC digital camera and Zeiss AxioVision imaging software.
Standardized fractures
with pin stabilization were made in femora of adult mice as previously described (Tsuji et al., 2006) . Fractured and non-fractured contralateral controls femurs were collected 3 days after fracture, processed for paraffin sectioning, and subjected to lacZ staining.
LacZ staining
Tissues were embedded in optimal cutting temperature compound (OCT) on dry ice and frozen sections were prepared for beta-galactosidase staining as previously described (Kokabu et al., 2012) .
Cryohistology for endogenously expressed reporters
Tissues were fixed in 10% neutral buffered formalin overnight at room temperature. If necessary, tissues were decalcified in 14% EDTA pH 8.0 prior cryopreservation in a 30% sucrose gradient, then embedded in optimal cutting temperature compound (OCT) on dry ice. Frozen sections from adult bones were collected on a CryoJane tape system and mounted with Vectashield plus DAPI (Vector Labs).
Col1A1 in situ hybridization
P14 mouse hindlimbs were fixed, paraffin processed and sectioned in the coronal plane using standard methods. In vitro transcription to generate riboprobes was performed using standard protocols and reagents (Promega). In situ hybridization with digoxigenin-labeled Col1A1 probe was carried out as described previously (Gamer et al., 2009 ).
Three-point bending
Femurs were placed on the lower support points of a three-point bending fixture with the anterior side down (i.e., bending about the medial-lateral plane). The span (L) between the lower supports was 7 mm or 8 mm depending on genotype. Hydrated bone was loaded-to-failure at 3.0 mm/min (Dynamight 8841, Instron, Canton, OH) to generate the force vs. displacement (P-d) curve. The primary structural properties were rigidity (d), which is the slope of the linear portion of the curve multiplied by L (Ornitz and Legeai-Mallet, 2017 )/48, ultimate moment (P u ÂL/4), which is the peak bending moment endured by the mid-shaft, the post-yield deflection (PYD), which is the normalized displacement at failure minus the displacement at yielding, and work-to-fracture (W f ), which is the area under the normalized P-d curve generated by the test (i.e., multiplied by 12/L2 to adjust for differences in span).
Serology
Blood was collected by heart puncture after euthanasia for serum biochemistry. Serum IGF-1 was measured with ELISA kit (Immuno diagnostics, Inc, CA, USA) from 2-, 4-and 10-week-old mice. Analysis was performed as suggested by the manufacturer and, in all cases, serum was diluted 1:10.
Recombinant growth factors
Recombinant human BMP2 (200 ng/ml; Genetics Institute). Recombinant human BMP7 and GDF5 (200 ng/ml; R and D Systems). Recombinant mouse Wnt3a, Wnt10 (40 ng/ml; R and D Systems). Noggin (10 ug/ml; R and D Systems).
Immunoblot
Bones were cleaned of soft tissue and marrow, snap frozen in liquid nitrogen, and pulverized for 10 min using a Bullet Blender and Navy Lysis Beads in RIPA buffer containing Halt protease and phosphatase inhibitors (Pierce). Proteins were separated by SDS-page electrophoresis and immunoblotted with the following antibodies at 1:1000 dilutions: phospho-Smad1/5 (Cell Signaling #9511), Smad1 (Cell Signaling # 9743), and alpha-Tubulin (Sigma, #T6074).
Bone marrow stromal cells (BMSC)
Bone marrow from 4 to 6 month-old mice (male and female) was collected as previously described (Salazar et al., 2013) and plated in BMSC medium (ascorbic acid free a-MEM (Invitrogen) containing 20% FBS, 40 mM L-glutamine, 100 U/ml penicillin-G, and 100 mg/ml streptomycin). After 3 days, non-adherent cells were removed by vigorous washing. Osteoblast differentiation BMSC were seeded in BMSC medium at 35,000 cells/well in 96-well dishes (for alizarin red staining) or 300,000 cells per well in 24-well dishes (for RNA or protein). Confluent cultures were stimulated on day one with Osteogenic Medium (OM: BMSC medium plus 50 mg/ml ascorbic acid and 10 mM b-glycerophosphate)±200 ng/ml rhBMP2 (Genetics Institute) or 40 ng/ml recombinant mouse Wnt3a (R and D Systems). Alizarin red Fixed cells were stained for 30 mins in 0.4% aqueous solution of alizarin red S (Sigma). ARS was eluted in 10% glacial acetic acid, pH was adjusted with 10% ammonium hydroxide, and absorbance was measured at 405 nm. QPCR Cells were scraped into 250 ml/well of Trizol, homogenized five times through a 22 g needle and five times through a 25 g needle. Genomic DNA was digested with 50 ul gDNase solution (RNeasy Plus Universal Kit, Qiagen). The organic phase was separated using 50 ml chloroform, and mixed with 150 ml of 70% ethanol before loading onto an RNeasy spin column and purifying according to manufacturer's instructions. RNA was reverse transcribed with EcoDry Premix (Clonetech). Data were normalized to beta-actin, analyzed using DDCT method, and expressed as mean ±s.d relative to Bmp2 F/F cells cultured in osteogenic medium.
Two-tailed student's t-test was utilized to calculate P-values.
Periosteal cells
Periosteal cells were isolated from hindlimbs and forelimbs of 4 week-old BMP2 F/F ; Prx1-Cre mice.
Litter mate BMP2 F/F or BMP2 F/+ : Prx1-Cre were used as controls. In brief, long bone were carefully cleaned from muscles and the ends of the bones sealed with agarose. The bones were digested with collagenase and dispase 3 mg/ml (Sigma) for 45 min in a shaking 37˚C water bath. Cells were collected, strained and plated in 5% CO2% and 5% O2 incubator. After expansion RNA was extracted. Cells from BMP2 F/F ; Prx1-Cre mice do not grow well, so cultures were supplemented with 10 ng/ml rBMP2. For each isolation bones from 3 to 4 mice/genotype were pooled to create one culture. Three separate isolations were performed for gene expression analysis. 500 ng RNA was reverse transcribed to cDNA using the iSCRIPT kit (BioRad) and qPCR analysis performed (SYBR GREEN). The data presented as mean ± SEM. BMP4 was detected only in one of the samples.
Peak calling
All sequenced reads were mapped using the tool for fast and sensitive reads alignment, Bowtie 2 (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml), onto the UCSC mm10 reference mouse genome. The command 'findPeaks' from the HOMER tool package (http://homer.salk.edu/homer/) was used to identify enriched regions in the Bcl9 immunoprecipitation samples using the '-style = factor' option (routinely used for transcription factors with the aim of identifying the precise location of DNA-protein contact). Input and IgG samples were used as enrichment-normalization controls. Peak calling parameters were adjusted as following: L = 4 (filtering based on local signal), F = 4 (fold-change in target experiment over input control). Annotation of peaks' position (i.e. the association of individual peaks to nearby annotated genes) was obtained by the all-in-one program called 'annotatePeaks.pl'. Finally, the HOMER command 'makeUCSCfile' was used to produce bedGraph formatted files that can be uploaded as custom tracks and visualized in the UCSC genome browser (http://genome.ucsc.edu/).
Association analyses in the DiscovEHR cohort
Sample preparation and sequencing was performed as described previously. Exome capture was performed with either NimbleGen (SeqCap VCRome). Sequence reads were aligned to GRCh38. Variant calling and genotyping was performed as described in detail previously (Dewey et al., 2016) . Gene definitions were restricted those genes and transcripts with annotated start and stop codons; a total of 19,467 protein-coding genes. Genotypes were coded as follows: homozygous reference as 0, heterozygotes as 1, and homozygous alternative or compound heterozygous as 2. Only individuals of European ancestry were analyzed. For clinical diagnoses, ICD-10 codes were collapsed into hierarchical clinical disease groups and corresponding controls using a modified version of the groupings proposed previously (Denny et al., 2010; Denny et al., 2013) . Case assignment for the 14,128 ICD-10 based diagnoses required one or more of the following: a problem list entry of the diagnosis code or an encounter diagnosis code entered for two separate clinical encounters on different calendar days. Firth logistic regression was performed using PLINKv1.9 (Chang et al., 2015) , with adjustment for age, age squared, sex, and the first four principal components of ancestry. Gene-trait association results meeting the Bonferroni corrected significance threshold 0.05/268192 (p<1.86-7) are reported.
Statistical analysis
Methods for statistical analysis are specific to various components of the study and are described in detail for each type of experiment.
